CoTherix™: An Actelion Company

CoTherix is an affiliate of Actelion Pharmaceuticals Ltd, a biopharmaceutical company headquartered in Allschwil/Basel, Switzerland, that focuses on the discovery, development, and commercialization of innovative treatments to serve unmet medical needs.

Actelion’s US offices are located in South San Francisco, in the heart of California’s pharmaceutical and biotechnology development region.

Product: Miglustat - Prescribing Information